Myelofibrosis patients in Belgium: disease characteristics-Reference-Cited by-同舟云学术

Myelofibrosis patients in Belgium: disease characteristics

Published:2014-11-06 Issue:2 Volume:70 Page:105-111
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Devos T.,Zachée P.,Bron D.,Noens L.,Droogenbroeck J. Van,Mineur P.,Beguin Y.,Berneman Z.,Benghiat F. S.,Kentos A.,Chatelain C.,Demuynck H.,Lemmens J.,Eygen K. Van,Theunissen K.,Trullemans F.,Pierre P.,Pluymers W.,Knoops L.

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1179/2295333714Y.0000000097

Reference48 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

2. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs)

3. Myelofibrosis with Myeloid Metaplasia

4. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

5. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management;Blood Reviews;2021-01

2. The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication;Clinical Lymphoma Myeloma and Leukemia;2020-07

3. Recommendations on the use of ruxolitinib for the treatment of myelofibrosis;Hematology;2017-10-12

4. Dilemmas in a pregnant woman with myelofibrosis secondary to signet ring adenocarcinoma: a case report;BMC Cancer;2017-10-11

5. Managing patients with myelofibrosis and low platelet counts;Annals of Hematology;2016-05-21